Arkolith/Insider Trading/LSTA/Form 4

Mazzo David J

President & CEO, DirectorLISATA THERAPEUTICS, INC. (LSTA) · full profile →Form 4 · filed Jan 13, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
5 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 10, 2025Tax withholding(F)3K$3.73$12K265K
Jan 9, 2025Grant(A)81K—$0295K
Jan 9, 2025Tax withholding(F)7K$3.80$27K268K
Jan 9, 2025Tax withholding(F)11K$3.80$42K275K
Jan 9, 2025Tax withholding(F)9K$3.80$36K286K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 9, 2025Grant(A)40K—$040K

Transaction Codes

F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001334549-25-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for LISATA THERAPEUTICS, INC.

Build

Ask your agent about LSTA insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001334549-25-000002"
Ask your agent
Use Arkolith to summarize insider buying and selling at LISATA THERAPEUTICS, INC.
over the last 90 days and cite the filings.